1 Study Coverage 1.1 High Blood Pressure Drugs (Hypertension) Product Introduction 1.2 Market by Type 1.2.1 Global High Blood Pressure Drugs (Hypertension) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 ACEI 1.2.3 CCB 1.2.4 ARB 1.3 Market by Application 1.3.1 Global High Blood Pressure Drugs (Hypertension) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 Online Pharmacy 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global High Blood Pressure Drugs (Hypertension) Sales Estimates and Forecasts 2018-2029 2.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Region 2.2.1 Global High Blood Pressure Drugs (Hypertension) Revenue by Region: 2018 VS 2022 VS 2029 2.2.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Region (2018-2023) 2.2.3 Global High Blood Pressure Drugs (Hypertension) Revenue by Region (2024-2029) 2.2.4 Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Region (2018-2029) 2.3 Global High Blood Pressure Drugs (Hypertension) Sales Estimates and Forecasts 2018-2029 2.4 Global High Blood Pressure Drugs (Hypertension) Sales by Region 2.4.1 Global High Blood Pressure Drugs (Hypertension) Sales by Region: 2018 VS 2022 VS 2029 2.4.2 Global High Blood Pressure Drugs (Hypertension) Sales by Region (2018-2023) 2.4.3 Global High Blood Pressure Drugs (Hypertension) Sales by Region (2024-2029) 2.4.4 Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Region (2018-2029) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufactures 3.1 Global High Blood Pressure Drugs (Hypertension) Sales by Manufacturers 3.1.1 Global High Blood Pressure Drugs (Hypertension) Sales by Manufacturers (2018-2023) 3.1.2 Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Manufacturers (2018-2023) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of High Blood Pressure Drugs (Hypertension) in 2022 3.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Manufacturers 3.2.1 Global High Blood Pressure Drugs (Hypertension) Revenue by Manufacturers (2018-2023) 3.2.2 Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Manufacturers (2018-2023) 3.2.3 Global Top 10 and Top 5 Companies by High Blood Pressure Drugs (Hypertension) Revenue in 2022 3.3 Global Key Players of High Blood Pressure Drugs (Hypertension), Industry Ranking, 2021 VS 2022 VS 2023 3.4 Global High Blood Pressure Drugs (Hypertension) Sales Price by Manufacturers 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global High Blood Pressure Drugs (Hypertension) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of High Blood Pressure Drugs (Hypertension), Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of High Blood Pressure Drugs (Hypertension), Product Offered and Application 3.8 Global Key Manufacturers of High Blood Pressure Drugs (Hypertension), Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global High Blood Pressure Drugs (Hypertension) Sales by Type 4.1.1 Global High Blood Pressure Drugs (Hypertension) Historical Sales by Type (2018-2023) 4.1.2 Global High Blood Pressure Drugs (Hypertension) Forecasted Sales by Type (2024-2029) 4.1.3 Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2018-2029) 4.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Type 4.2.1 Global High Blood Pressure Drugs (Hypertension) Historical Revenue by Type (2018-2023) 4.2.2 Global High Blood Pressure Drugs (Hypertension) Forecasted Revenue by Type (2024-2029) 4.2.3 Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Type (2018-2029) 4.3 Global High Blood Pressure Drugs (Hypertension) Price by Type 4.3.1 Global High Blood Pressure Drugs (Hypertension) Price by Type (2018-2023) 4.3.2 Global High Blood Pressure Drugs (Hypertension) Price Forecast by Type (2024-2029) 5 Market Size by Application 5.1 Global High Blood Pressure Drugs (Hypertension) Sales by Application 5.1.1 Global High Blood Pressure Drugs (Hypertension) Historical Sales by Application (2018-2023) 5.1.2 Global High Blood Pressure Drugs (Hypertension) Forecasted Sales by Application (2024-2029) 5.1.3 Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2018-2029) 5.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Application 5.2.1 Global High Blood Pressure Drugs (Hypertension) Historical Revenue by Application (2018-2023) 5.2.2 Global High Blood Pressure Drugs (Hypertension) Forecasted Revenue by Application (2024-2029) 5.2.3 Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Application (2018-2029) 5.3 Global High Blood Pressure Drugs (Hypertension) Price by Application 5.3.1 Global High Blood Pressure Drugs (Hypertension) Price by Application (2018-2023) 5.3.2 Global High Blood Pressure Drugs (Hypertension) Price Forecast by Application (2024-2029) 6 US & Canada 6.1 US & Canada High Blood Pressure Drugs (Hypertension) Market Size by Type 6.1.1 US & Canada High Blood Pressure Drugs (Hypertension) Sales by Type (2018-2029) 6.1.2 US & Canada High Blood Pressure Drugs (Hypertension) Revenue by Type (2018-2029) 6.2 US & Canada High Blood Pressure Drugs (Hypertension) Market Size by Application 6.2.1 US & Canada High Blood Pressure Drugs (Hypertension) Sales by Application (2018-2029) 6.2.2 US & Canada High Blood Pressure Drugs (Hypertension) Revenue by Application (2018-2029) 6.3 US & Canada High Blood Pressure Drugs (Hypertension) Market Size by Country 6.3.1 US & Canada High Blood Pressure Drugs (Hypertension) Revenue by Country: 2018 VS 2022 VS 2029 6.3.2 US & Canada High Blood Pressure Drugs (Hypertension) Sales by Country (2018-2029) 6.3.3 US & Canada High Blood Pressure Drugs (Hypertension) Revenue by Country (2018-2029) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe High Blood Pressure Drugs (Hypertension) Market Size by Type 7.1.1 Europe High Blood Pressure Drugs (Hypertension) Sales by Type (2018-2029) 7.1.2 Europe High Blood Pressure Drugs (Hypertension) Revenue by Type (2018-2029) 7.2 Europe High Blood Pressure Drugs (Hypertension) Market Size by Application 7.2.1 Europe High Blood Pressure Drugs (Hypertension) Sales by Application (2018-2029) 7.2.2 Europe High Blood Pressure Drugs (Hypertension) Revenue by Application (2018-2029) 7.3 Europe High Blood Pressure Drugs (Hypertension) Market Size by Country 7.3.1 Europe High Blood Pressure Drugs (Hypertension) Revenue by Country: 2018 VS 2022 VS 2029 7.3.2 Europe High Blood Pressure Drugs (Hypertension) Sales by Country (2018-2029) 7.3.3 Europe High Blood Pressure Drugs (Hypertension) Revenue by Country (2018-2029) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China High Blood Pressure Drugs (Hypertension) Market Size 8.1.1 China High Blood Pressure Drugs (Hypertension) Sales (2018-2029) 8.1.2 China High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) 8.2 China High Blood Pressure Drugs (Hypertension) Market Size by Application 8.2.1 China High Blood Pressure Drugs (Hypertension) Sales by Application (2018-2029) 8.2.2 China High Blood Pressure Drugs (Hypertension) Revenue by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia High Blood Pressure Drugs (Hypertension) Market Size by Type 9.1.1 Asia High Blood Pressure Drugs (Hypertension) Sales by Type (2018-2029) 9.1.2 Asia High Blood Pressure Drugs (Hypertension) Revenue by Type (2018-2029) 9.2 Asia High Blood Pressure Drugs (Hypertension) Market Size by Application 9.2.1 Asia High Blood Pressure Drugs (Hypertension) Sales by Application (2018-2029) 9.2.2 Asia High Blood Pressure Drugs (Hypertension) Revenue by Application (2018-2029) 9.3 Asia High Blood Pressure Drugs (Hypertension) Sales by Region 9.3.1 Asia High Blood Pressure Drugs (Hypertension) Revenue by Region: 2018 VS 2022 VS 2029 9.3.2 Asia High Blood Pressure Drugs (Hypertension) Revenue by Region (2018-2029) 9.3.3 Asia High Blood Pressure Drugs (Hypertension) Sales by Region (2018-2029) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Market Size by Type 10.1.1 Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales by Type (2018-2029) 10.1.2 Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue by Type (2018-2029) 10.2 Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Market Size by Application 10.2.1 Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales by Application (2018-2029) 10.2.2 Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue by Application (2018-2029) 10.3 Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales by Country 10.3.1 Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue by Country: 2018 VS 2022 VS 2029 10.3.2 Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue by Country (2018-2029) 10.3.3 Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales by Country (2018-2029) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Company Profiles 11.1 Eli Lilly 11.1.1 Eli Lilly Company Information 11.1.2 Eli Lilly Overview 11.1.3 Eli Lilly High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2018-2023) 11.1.4 Eli Lilly High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Eli Lilly Recent Developments 11.2 Pfizer 11.2.1 Pfizer Company Information 11.2.2 Pfizer Overview 11.2.3 Pfizer High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2018-2023) 11.2.4 Pfizer High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Pfizer Recent Developments 11.3 Bayer 11.3.1 Bayer Company Information 11.3.2 Bayer Overview 11.3.3 Bayer High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2018-2023) 11.3.4 Bayer High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Bayer Recent Developments 11.4 Symplmed 11.4.1 Symplmed Company Information 11.4.2 Symplmed Overview 11.4.3 Symplmed High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2018-2023) 11.4.4 Symplmed High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Symplmed Recent Developments 11.5 Novartis 11.5.1 Novartis Company Information 11.5.2 Novartis Overview 11.5.3 Novartis High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2018-2023) 11.5.4 Novartis High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Novartis Recent Developments 11.6 Merck 11.6.1 Merck Company Information 11.6.2 Merck Overview 11.6.3 Merck High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2018-2023) 11.6.4 Merck High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Merck Recent Developments 11.7 Sanofi 11.7.1 Sanofi Company Information 11.7.2 Sanofi Overview 11.7.3 Sanofi High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2018-2023) 11.7.4 Sanofi High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Sanofi Recent Developments 11.8 Boryung 11.8.1 Boryung Company Information 11.8.2 Boryung Overview 11.8.3 Boryung High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2018-2023) 11.8.4 Boryung High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Boryung Recent Developments 11.9 Reata Pharmaceuticals 11.9.1 Reata Pharmaceuticals Company Information 11.9.2 Reata Pharmaceuticals Overview 11.9.3 Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2018-2023) 11.9.4 Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Reata Pharmaceuticals Recent Developments 11.10 Lung Biotechnology 11.10.1 Lung Biotechnology Company Information 11.10.2 Lung Biotechnology Overview 11.10.3 Lung Biotechnology High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2018-2023) 11.10.4 Lung Biotechnology High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Lung Biotechnology Recent Developments 11.11 Yuhan 11.11.1 Yuhan Company Information 11.11.2 Yuhan Overview 11.11.3 Yuhan High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2018-2023) 11.11.4 Yuhan High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Yuhan Recent Developments 11.12 Takeda 11.12.1 Takeda Company Information 11.12.2 Takeda Overview 11.12.3 Takeda High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2018-2023) 11.12.4 Takeda High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Takeda Recent Developments 11.13 Alvogen 11.13.1 Alvogen Company Information 11.13.2 Alvogen Overview 11.13.3 Alvogen High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2018-2023) 11.13.4 Alvogen High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 Alvogen Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 High Blood Pressure Drugs (Hypertension) Industry Chain Analysis 12.2 High Blood Pressure Drugs (Hypertension) Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 High Blood Pressure Drugs (Hypertension) Production Mode & Process 12.4 High Blood Pressure Drugs (Hypertension) Sales and Marketing 12.4.1 High Blood Pressure Drugs (Hypertension) Sales Channels 12.4.2 High Blood Pressure Drugs (Hypertension) Distributors 12.5 High Blood Pressure Drugs (Hypertension) Customers 13 Market Dynamics 13.1 High Blood Pressure Drugs (Hypertension) Industry Trends 13.2 High Blood Pressure Drugs (Hypertension) Market Drivers 13.3 High Blood Pressure Drugs (Hypertension) Market Challenges 13.4 High Blood Pressure Drugs (Hypertension) Market Restraints 14 Key Findings in The Global High Blood Pressure Drugs (Hypertension) Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global High Blood Pressure Drugs (Hypertension) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million) Table 2. Major Manufacturers of ACEI Table 3. Major Manufacturers of CCB Table 4. Major Manufacturers of ARB Table 5. Global High Blood Pressure Drugs (Hypertension) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million) Table 6. Global High Blood Pressure Drugs (Hypertension) Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 7. Global High Blood Pressure Drugs (Hypertension) Revenue by Region (2018-2023) & (US$ Million) Table 8. Global High Blood Pressure Drugs (Hypertension) Revenue by Region (2024-2029) & (US$ Million) Table 9. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Region (2018-2023) Table 10. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Region (2024-2029) Table 11. Global High Blood Pressure Drugs (Hypertension) Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 12. Global High Blood Pressure Drugs (Hypertension) Sales by Region (2018-2023) & (K MT) Table 13. Global High Blood Pressure Drugs (Hypertension) Sales by Region (2024-2029) & (K MT) Table 14. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Region (2018-2023) Table 15. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Region (2024-2029) Table 16. Global High Blood Pressure Drugs (Hypertension) Sales by Manufacturers (2018-2023) & (K MT) Table 17. Global High Blood Pressure Drugs (Hypertension) Sales Share by Manufacturers (2018-2023) Table 18. Global High Blood Pressure Drugs (Hypertension) Revenue by Manufacturers (2018-2023) & (US$ Million) Table 19. Global High Blood Pressure Drugs (Hypertension) Revenue Share by Manufacturers (2018-2023) Table 20. Global Key Players of High Blood Pressure Drugs (Hypertension), Industry Ranking, 2021 VS 2022 VS 2023 Table 21. High Blood Pressure Drugs (Hypertension) Price by Manufacturers 2018-2023 (USD/MT) Table 22. Global High Blood Pressure Drugs (Hypertension) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Global High Blood Pressure Drugs (Hypertension) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High Blood Pressure Drugs (Hypertension) as of 2022) Table 24. Global Key Manufacturers of High Blood Pressure Drugs (Hypertension), Manufacturing Base Distribution and Headquarters Table 25. Global Key Manufacturers of High Blood Pressure Drugs (Hypertension), Product Offered and Application Table 26. Global Key Manufacturers of High Blood Pressure Drugs (Hypertension), Date of Enter into This Industry Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global High Blood Pressure Drugs (Hypertension) Sales by Type (2018-2023) & (K MT) Table 29. Global High Blood Pressure Drugs (Hypertension) Sales by Type (2024-2029) & (K MT) Table 30. Global High Blood Pressure Drugs (Hypertension) Sales Share by Type (2018-2023) Table 31. Global High Blood Pressure Drugs (Hypertension) Sales Share by Type (2024-2029) Table 32. Global High Blood Pressure Drugs (Hypertension) Revenue by Type (2018-2023) & (US$ Million) Table 33. Global High Blood Pressure Drugs (Hypertension) Revenue by Type (2024-2029) & (US$ Million) Table 34. Global High Blood Pressure Drugs (Hypertension) Revenue Share by Type (2018-2023) Table 35. Global High Blood Pressure Drugs (Hypertension) Revenue Share by Type (2024-2029) Table 36. High Blood Pressure Drugs (Hypertension) Price by Type (2018-2023) & (USD/MT) Table 37. Global High Blood Pressure Drugs (Hypertension) Price Forecast by Type (2024-2029) & (USD/MT) Table 38. Global High Blood Pressure Drugs (Hypertension) Sales by Application (2018-2023) & (K MT) Table 39. Global High Blood Pressure Drugs (Hypertension) Sales by Application (2024-2029) & (K MT) Table 40. Global High Blood Pressure Drugs (Hypertension) Sales Share by Application (2018-2023) Table 41. Global High Blood Pressure Drugs (Hypertension) Sales Share by Application (2024-2029) Table 42. Global High Blood Pressure Drugs (Hypertension) Revenue by Application (2018-2023) & (US$ Million) Table 43. Global High Blood Pressure Drugs (Hypertension) Revenue by Application (2024-2029) & (US$ Million) Table 44. Global High Blood Pressure Drugs (Hypertension) Revenue Share by Application (2018-2023) Table 45. Global High Blood Pressure Drugs (Hypertension) Revenue Share by Application (2024-2029) Table 46. High Blood Pressure Drugs (Hypertension) Price by Application (2018-2023) & (USD/MT) Table 47. Global High Blood Pressure Drugs (Hypertension) Price Forecast by Application (2024-2029) & (USD/MT) Table 48. US & Canada High Blood Pressure Drugs (Hypertension) Sales by Type (2018-2023) & (K MT) Table 49. US & Canada High Blood Pressure Drugs (Hypertension) Sales by Type (2024-2029) & (K MT) Table 50. US & Canada High Blood Pressure Drugs (Hypertension) Revenue by Type (2018-2023) & (US$ Million) Table 51. US & Canada High Blood Pressure Drugs (Hypertension) Revenue by Type (2024-2029) & (US$ Million) Table 52. US & Canada High Blood Pressure Drugs (Hypertension) Sales by Application (2018-2023) & (K MT) Table 53. US & Canada High Blood Pressure Drugs (Hypertension) Sales by Application (2024-2029) & (K MT) Table 54. US & Canada High Blood Pressure Drugs (Hypertension) Revenue by Application (2018-2023) & (US$ Million) Table 55. US & Canada High Blood Pressure Drugs (Hypertension) Revenue by Application (2024-2029) & (US$ Million) Table 56. US & Canada High Blood Pressure Drugs (Hypertension) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 57. US & Canada High Blood Pressure Drugs (Hypertension) Revenue by Country (2018-2023) & (US$ Million) Table 58. US & Canada High Blood Pressure Drugs (Hypertension) Revenue by Country (2024-2029) & (US$ Million) Table 59. US & Canada High Blood Pressure Drugs (Hypertension) Sales by Country (2018-2023) & (K MT) Table 60. US & Canada High Blood Pressure Drugs (Hypertension) Sales by Country (2024-2029) & (K MT) Table 61. Europe High Blood Pressure Drugs (Hypertension) Sales by Type (2018-2023) & (K MT) Table 62. Europe High Blood Pressure Drugs (Hypertension) Sales by Type (2024-2029) & (K MT) Table 63. Europe High Blood Pressure Drugs (Hypertension) Revenue by Type (2018-2023) & (US$ Million) Table 64. Europe High Blood Pressure Drugs (Hypertension) Revenue by Type (2024-2029) & (US$ Million) Table 65. Europe High Blood Pressure Drugs (Hypertension) Sales by Application (2018-2023) & (K MT) Table 66. Europe High Blood Pressure Drugs (Hypertension) Sales by Application (2024-2029) & (K MT) Table 67. Europe High Blood Pressure Drugs (Hypertension) Revenue by Application (2018-2023) & (US$ Million) Table 68. Europe High Blood Pressure Drugs (Hypertension) Revenue by Application (2024-2029) & (US$ Million) Table 69. Europe High Blood Pressure Drugs (Hypertension) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 70. Europe High Blood Pressure Drugs (Hypertension) Revenue by Country (2018-2023) & (US$ Million) Table 71. Europe High Blood Pressure Drugs (Hypertension) Revenue by Country (2024-2029) & (US$ Million) Table 72. Europe High Blood Pressure Drugs (Hypertension) Sales by Country (2018-2023) & (K MT) Table 73. Europe High Blood Pressure Drugs (Hypertension) Sales by Country (2024-2029) & (K MT) Table 74. China High Blood Pressure Drugs (Hypertension) Sales by Type (2018-2023) & (K MT) Table 75. China High Blood Pressure Drugs (Hypertension) Sales by Type (2024-2029) & (K MT) Table 76. China High Blood Pressure Drugs (Hypertension) Revenue by Type (2018-2023) & (US$ Million) Table 77. China High Blood Pressure Drugs (Hypertension) Revenue by Type (2024-2029) & (US$ Million) Table 78. China High Blood Pressure Drugs (Hypertension) Sales by Application (2018-2023) & (K MT) Table 79. China High Blood Pressure Drugs (Hypertension) Sales by Application (2024-2029) & (K MT) Table 80. China High Blood Pressure Drugs (Hypertension) Revenue by Application (2018-2023) & (US$ Million) Table 81. China High Blood Pressure Drugs (Hypertension) Revenue by Application (2024-2029) & (US$ Million) Table 82. Asia High Blood Pressure Drugs (Hypertension) Sales by Type (2018-2023) & (K MT) Table 83. Asia High Blood Pressure Drugs (Hypertension) Sales by Type (2024-2029) & (K MT) Table 84. Asia High Blood Pressure Drugs (Hypertension) Revenue by Type (2018-2023) & (US$ Million) Table 85. Asia High Blood Pressure Drugs (Hypertension) Revenue by Type (2024-2029) & (US$ Million) Table 86. Asia High Blood Pressure Drugs (Hypertension) Sales by Application (2018-2023) & (K MT) Table 87. Asia High Blood Pressure Drugs (Hypertension) Sales by Application (2024-2029) & (K MT) Table 88. Asia High Blood Pressure Drugs (Hypertension) Revenue by Application (2018-2023) & (US$ Million) Table 89. Asia High Blood Pressure Drugs (Hypertension) Revenue by Application (2024-2029) & (US$ Million) Table 90. Asia High Blood Pressure Drugs (Hypertension) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 91. Asia High Blood Pressure Drugs (Hypertension) Revenue by Region (2018-2023) & (US$ Million) Table 92. Asia High Blood Pressure Drugs (Hypertension) Revenue by Region (2024-2029) & (US$ Million) Table 93. Asia High Blood Pressure Drugs (Hypertension) Sales by Region (2018-2023) & (K MT) Table 94. Asia High Blood Pressure Drugs (Hypertension) Sales by Region (2024-2029) & (K MT) Table 95. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales by Type (2018-2023) & (K MT) Table 96. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales by Type (2024-2029) & (K MT) Table 97. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue by Type (2018-2023) & (US$ Million) Table 98. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue by Type (2024-2029) & (US$ Million) Table 99. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales by Application (2018-2023) & (K MT) Table 100. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales by Application (2024-2029) & (K MT) Table 101. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue by Application (2018-2023) & (US$ Million) Table 102. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue by Application (2024-2029) & (US$ Million) Table 103. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 104. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue by Country (2018-2023) & (US$ Million) Table 105. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue by Country (2024-2029) & (US$ Million) Table 106. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales by Country (2018-2023) & (K MT) Table 107. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales by Country (2024-2029) & (K MT) Table 108. Eli Lilly Company Information Table 109. Eli Lilly Description and Major Businesses Table 110. Eli Lilly High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 111. Eli Lilly High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications Table 112. Eli Lilly Recent Developments Table 113. Pfizer Company Information Table 114. Pfizer Description and Major Businesses Table 115. Pfizer High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 116. Pfizer High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications Table 117. Pfizer Recent Developments Table 118. Bayer Company Information Table 119. Bayer Description and Major Businesses Table 120. Bayer High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 121. Bayer High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications Table 122. Bayer Recent Developments Table 123. Symplmed Company Information Table 124. Symplmed Description and Major Businesses Table 125. Symplmed High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 126. Symplmed High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications Table 127. Symplmed Recent Developments Table 128. Novartis Company Information Table 129. Novartis Description and Major Businesses Table 130. Novartis High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 131. Novartis High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications Table 132. Novartis Recent Developments Table 133. Merck Company Information Table 134. Merck Description and Major Businesses Table 135. Merck High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 136. Merck High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications Table 137. Merck Recent Developments Table 138. Sanofi Company Information Table 139. Sanofi Description and Major Businesses Table 140. Sanofi High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 141. Sanofi High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications Table 142. Sanofi Recent Developments Table 143. Boryung Company Information Table 144. Boryung Description and Major Businesses Table 145. Boryung High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 146. Boryung High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications Table 147. Boryung Recent Developments Table 148. Reata Pharmaceuticals Company Information Table 149. Reata Pharmaceuticals Description and Major Businesses Table 150. Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 151. Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications Table 152. Reata Pharmaceuticals Recent Developments Table 153. Lung Biotechnology Company Information Table 154. Lung Biotechnology Description and Major Businesses Table 155. Lung Biotechnology High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 156. Lung Biotechnology High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications Table 157. Lung Biotechnology Recent Developments Table 158. Yuhan Company Information Table 159. Yuhan Description and Major Businesses Table 160. Yuhan High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 161. Yuhan High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications Table 162. Yuhan Recent Developments Table 163. Takeda Company Information Table 164. Takeda Description and Major Businesses Table 165. Takeda High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 166. Takeda High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications Table 167. Takeda Recent Developments Table 168. Alvogen Company Information Table 169. Alvogen Description and Major Businesses Table 170. Alvogen High Blood Pressure Drugs (Hypertension) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023) Table 171. Alvogen High Blood Pressure Drugs (Hypertension) Product Model Numbers, Pictures, Descriptions and Specifications Table 172. Alvogen Recent Developments Table 173. Key Raw Materials Lists Table 174. Raw Materials Key Suppliers Lists Table 175. High Blood Pressure Drugs (Hypertension) Distributors List Table 176. High Blood Pressure Drugs (Hypertension) Customers List Table 177. High Blood Pressure Drugs (Hypertension) Market Trends Table 178. High Blood Pressure Drugs (Hypertension) Market Drivers Table 179. High Blood Pressure Drugs (Hypertension) Market Challenges Table 180. High Blood Pressure Drugs (Hypertension) Market Restraints Table 181. Research Programs/Design for This Report Table 182. Key Data Information from Secondary Sources Table 183. Key Data Information from Primary Sources List of Figures Figure 1. High Blood Pressure Drugs (Hypertension) Product Picture Figure 2. Global High Blood Pressure Drugs (Hypertension) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million) Figure 3. Global High Blood Pressure Drugs (Hypertension) Market Share by Type in 2022 & 2029 Figure 4. ACEI Product Picture Figure 5. CCB Product Picture Figure 6. ARB Product Picture Figure 7. Global High Blood Pressure Drugs (Hypertension) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million) Figure 8. Global High Blood Pressure Drugs (Hypertension) Market Share by Application in 2022 & 2029 Figure 9. Hospital Pharmacy Figure 10. Retail Pharmacy Figure 11. Online Pharmacy Figure 12. High Blood Pressure Drugs (Hypertension) Report Years Considered Figure 13. Global High Blood Pressure Drugs (Hypertension) Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 14. Global High Blood Pressure Drugs (Hypertension) Revenue 2018-2029 (US$ Million) Figure 15. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Region in Percentage: 2022 Versus 2029 Figure 16. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Region (2018-2029) Figure 17. Global High Blood Pressure Drugs (Hypertension) Sales 2018-2029 ((K MT) Figure 18. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Region (2018-2029) Figure 19. US & Canada High Blood Pressure Drugs (Hypertension) Sales YoY (2018-2029) & (K MT) Figure 20. US & Canada High Blood Pressure Drugs (Hypertension) Revenue YoY (2018-2029) & (US$ Million) Figure 21. Europe High Blood Pressure Drugs (Hypertension) Sales YoY (2018-2029) & (K MT) Figure 22. Europe High Blood Pressure Drugs (Hypertension) Revenue YoY (2018-2029) & (US$ Million) Figure 23. China High Blood Pressure Drugs (Hypertension) Sales YoY (2018-2029) & (K MT) Figure 24. China High Blood Pressure Drugs (Hypertension) Revenue YoY (2018-2029) & (US$ Million) Figure 25. Asia (excluding China) High Blood Pressure Drugs (Hypertension) Sales YoY (2018-2029) & (K MT) Figure 26. Asia (excluding China) High Blood Pressure Drugs (Hypertension) Revenue YoY (2018-2029) & (US$ Million) Figure 27. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales YoY (2018-2029) & (K MT) Figure 28. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue YoY (2018-2029) & (US$ Million) Figure 29. The High Blood Pressure Drugs (Hypertension) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022 Figure 30. The Top 5 and 10 Largest Manufacturers of High Blood Pressure Drugs (Hypertension) in the World: Market Share by High Blood Pressure Drugs (Hypertension) Revenue in 2022 Figure 31. Global High Blood Pressure Drugs (Hypertension) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022 Figure 32. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2018-2029) Figure 33. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Type (2018-2029) Figure 34. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2018-2029) Figure 35. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Application (2018-2029) Figure 36. US & Canada High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2018-2029) Figure 37. US & Canada High Blood Pressure Drugs (Hypertension) Revenue Market Share by Type (2018-2029) Figure 38. US & Canada High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2018-2029) Figure 39. US & Canada High Blood Pressure Drugs (Hypertension) Revenue Market Share by Application (2018-2029) Figure 40. US & Canada High Blood Pressure Drugs (Hypertension) Revenue Share by Country (2018-2029) Figure 41. US & Canada High Blood Pressure Drugs (Hypertension) Sales Share by Country (2018-2029) Figure 42. U.S. High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 43. Canada High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 44. Europe High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2018-2029) Figure 45. Europe High Blood Pressure Drugs (Hypertension) Revenue Market Share by Type (2018-2029) Figure 46. Europe High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2018-2029) Figure 47. Europe High Blood Pressure Drugs (Hypertension) Revenue Market Share by Application (2018-2029) Figure 48. Europe High Blood Pressure Drugs (Hypertension) Revenue Share by Country (2018-2029) Figure 49. Europe High Blood Pressure Drugs (Hypertension) Sales Share by Country (2018-2029) Figure 50. Germany High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 51. France High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 52. U.K. High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 53. Italy High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 54. Russia High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 55. China High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2018-2029) Figure 56. China High Blood Pressure Drugs (Hypertension) Revenue Market Share by Type (2018-2029) Figure 57. China High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2018-2029) Figure 58. China High Blood Pressure Drugs (Hypertension) Revenue Market Share by Application (2018-2029) Figure 59. Asia High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2018-2029) Figure 60. Asia High Blood Pressure Drugs (Hypertension) Revenue Market Share by Type (2018-2029) Figure 61. Asia High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2018-2029) Figure 62. Asia High Blood Pressure Drugs (Hypertension) Revenue Market Share by Application (2018-2029) Figure 63. Asia High Blood Pressure Drugs (Hypertension) Revenue Share by Region (2018-2029) Figure 64. Asia High Blood Pressure Drugs (Hypertension) Sales Share by Region (2018-2029) Figure 65. Japan High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 66. South Korea High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 67. China Taiwan High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 68. Southeast Asia High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 69. India High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 70. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2018-2029) Figure 71. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue Market Share by Type (2018-2029) Figure 72. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2018-2029) Figure 73. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue Market Share by Application (2018-2029) Figure 74. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Revenue Share by Country (2018-2029) Figure 75. Middle East, Africa and Latin America High Blood Pressure Drugs (Hypertension) Sales Share by Country (2018-2029) Figure 76. Brazil High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 77. Mexico High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 78. Turkey High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 79. Israel High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 80. GCC Countries High Blood Pressure Drugs (Hypertension) Revenue (2018-2029) & (US$ Million) Figure 81. High Blood Pressure Drugs (Hypertension) Value Chain Figure 82. High Blood Pressure Drugs (Hypertension) Production Process Figure 83. Channels of Distribution Figure 84. Distributors Profiles Figure 85. Bottom-up and Top-down Approaches for This Report Figure 86. Data Triangulation Figure 87. Key Executives Interviewed

Eli Lilly Pfizer Bayer Symplmed Novartis Merck Sanofi Boryung Reata Pharmaceuticals Lung Biotechnology Yuhan Takeda Alvogen